Listen to José Ignacio Nolazco, MD, and Alejandro Nolazco, MD, discuss in Spanish the latest clinical data on immune checkpoint inhibitors for advanced urothelial cancer from an Argentinian perspective.
In this episode, José Ignacio Nolazco, MD, and Alejandro Nolazco, MD, discuss in Spanish the latest immuno-oncology developments in the treatment of urothelial cancer from an Argentinian perspective.
Presenters:
José Ignacio Nolazco, MD
Urology Fellow
Hospital Universitario Austral
Buenos Aires, Argentina
Alejandro Nolazco, MD
Associate Professor
Department of Urology
Universidad Austral and Universidad Católica Argentina
Buenos Aires, Argentina
Content based on an online IME program supported by educational grants from EMD Serono, Inc and Pfizer.
Link to full program, including associated downloadable slidesets and on-demand Webcast:
https://bit.ly/3kJC5SL